Adenovirus-Mediated Thymidine Kinase Gene Therapy in Combination with Topotecan for Patients with Recurrent Ovarian Cancer: 2.5-Year Follow-Up
- 1 December 2001
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 83 (3) , 549-554
- https://doi.org/10.1006/gyno.2001.6442
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Secondary cytoreductive surgery for recurrent epithelial ovarian cancerPublished by Elsevier ,2014
- 2nd-line-Chemotherapie nach Platin- oder Platin-Paclitaxel-haltiger Primärtherapie beim Ovarialkarzinom: eine systematische Übersicht der publizierten Daten bis 1998Geburtshilfe und Frauenheilkunde, 2000
- Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findingsObstetrics & Gynecology, 1999
- ?Obstetrics & Gynecology, 1997
- In VivoGene Therapy of Ovarian Cancer by Adenovirus-Mediated Thymidine Kinase Gene Transduction and Ganciclovir AdministrationGynecologic Oncology, 1996
- Secondary cytoreductive surgery for recurrent ovarian cancer. A prospective studyCancer, 1995
- Adenovirus‐mediated gene therapy of experimental gliomasJournal of Neuroscience Research, 1994
- In VitroEvidence That Metabolic Cooperation Is Responsible for the Bystander Effect Observed with HSVtkRetroviral Gene TherapyHuman Gene Therapy, 1993
- Descriptive epidemiology of ovarian cancer in EuropeGynecologic Oncology, 1992
- Operative Therapie progredienter oder rezidivierender maligner OvarialtumorenGeburtshilfe und Frauenheilkunde, 1991